BSEM

BioStem Technologies, Inc. Common Stock

1.13

USD

+0.09

+8.65%

Nov 06, 15:57 UTC -5

Closed

After-Market

1.06

-0.07

-6.19%

BioStem Technologies, Inc. Common Stock (BSEM) Profile

BioStem Technologies, Inc. Common Stock Profile

About

BioStem Technologies Inc. is a regenerative medicine company. It focused on the development, manufacture and commercialization of placental derived biologics. The company's portfolio of brands includes VENDAJE(R), VENDAJE AC(R) and VENDAJE OPTIC(R). BioStem Technologies Inc. is based in POMPANO BEACH, FLORIDA.

Info & Links

CEO

Headquarters

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

Auditor

Share holders

Employees

BioStem Technologies, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

19.79M

Enterprise Value

13.83M

Enterprise Value/EBITDA(ttm)

0.76

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

0.61

Price to Book(mrq)

0.73

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

90.32%

Operating Margin(ttm)

-48.08%

Profit Margin(ttm)

-82.30%

Return on Equity(ttm)

-60.22%

Return on Invested Capital(ttm)

-61.26%

Return on Assets(ttm)

-34.06%

Income Statement

Revenue(ttm)

34.59M

Revenue Per Share(ttm)

1.94

Gross Profit(ttm)

31.53M

EBITDA(ttm)³

18.29M

Net Income Available to Common(ttm)

-26.29M

Diluted EPS(ttm)

-1.60

Share Statistics

Beta (5Y Monthly)

0.36

52-Week Change

S&P 500 52-Week Change

14.38%

S&P 500 Member

Stock Optionable

Yes

Total Shares Outstanding¹

17.85M

Dividend Yield

0.00%

Float⁴

0.00

% Held by Insiders

% Held by Institutions

0.00%

Balance Sheet

Total Cash(mrq)

6.96M

Total Cash Per Share(mrq)

0.39

Total Debt(mrq)

1000.00K

Total Debt/Equity(mrq)

3.62%

Current Ratio(mrq)

0.98%

Quick Ratio(mrq)

0.76%

Book Value Per Share(mrq)

1.55

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.37

Free Cash Flow(ytd)

-6.42M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.